Ep 397 Inside 23andMe's $400 Million Acquisition of Lemonaid Health with Paul Johnson

<div style= "mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-vertical: paragraph; mso-element-anchor-horizontal: column; mso-element-top: .05pt; mso-height-rule: exactly;"> <table cellspacing="0" cellpadding="0" align="left"> <tbody> <tr> <td style="padding: 0cm 9.0pt 0cm 9.0pt;" align="left" valign= "top"> <p class="MsoNormal" style= "mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-vertical: paragraph; mso-element-anchor-horizontal: column; mso-element-top: .05pt; mso-height-rule: exactly;"> <span style= "font-size: 10.0pt; line-height: 107%; color: windowtext;">In 2013, Paul Johnson founded Lemonaid Health, one of the first digital healthcare platforms designed to offer virtual medical consultations and prescription services online.</span></p> <p class="MsoNormal" style= "mso-element: frame; mso-element-frame-hspace: 9.0pt; mso-element-wrap: around; mso-element-anchor-vertical: paragraph; mso-element-anchor-horizontal: column; mso-element-top: .05pt; mso-height-rule: exactly;"> <span lang="EN-US" style= "font-size: 10.0pt; line-height: 107%; color: windowtext; mso-ansi-language: EN-US;" xml:lang="EN-US"> <span style= "font-size: 10.0pt; line-height: 107%; font-family: 'Open Sans',sans-serif; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-CA; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">While the company got off to a slow start, the pandemic accelerated the adoption of online healthcare. By the end of 2021, Lemonaid had agreed to be acquired by the DNA testing outfit 23andMe, for $400 million of cash and stock.</span></span></p> </td> </tr> </tbody> </table> </div> <p> </p>